Nashville TN 骨髓纤维化临床试验
9项针对 骨髓纤维化的研究正在 Nashville及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
招募中1/2 期
- Tri-Star Centennial Medical Center, Nashville
- Vanderbilt University, Nashville
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
招募中3 期
- Vanderbilt-Ingram Cancer Center (VICC)-Nashville, Nashville
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
招募中1 期
- Tennessee Oncology, PLLC - Investigational Drug Services, Nashville
- Tristar BMT, Nashville
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
招募中2 期
- Vanderbilt University/Ingram Cancer Center, Nashville
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
招募中1 期
- Tristar Bmt/Tcto, Nashville
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
招募中2 期
- GSK Investigational Site, Nashville
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
招募中1 期
- Vanderbilt University Medical Center, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Nashville
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
招募中3 期
- Tennessee Oncology, Nashville
- Vanderbilt University Medical Center, Nashville
其他城市的 骨髓纤维化试验
- Houston, TX19 项研究
- New York City, NY18 项研究
- Boston, MA12 项研究
- Durham, NC12 项研究
- Columbus, OH11 项研究
- Seattle, WA11 项研究
- Miami, FL10 项研究
- Salt Lake City, UT10 项研究
- Baldwin Park, CA9 项研究
- Atlanta, GA9 项研究
- Tampa, FL9 项研究
- Cleveland, OH9 项研究
Nashville的其他研究
- 非小细胞肺癌97 项研究
- 乳腺癌81 项研究
- 转移性癌症70 项研究
- 结直肠癌69 项研究
- 癌症（所有类型）65 项研究
- 卵巢癌49 项研究
- 前列腺癌43 项研究
- 肺癌40 项研究
- 头颈鳞状细胞癌39 项研究
- 胰腺癌39 项研究
- 子宫内膜癌38 项研究
- 黑色素瘤33 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。